Notable Analyst Rating Changes 5/14: PFG, JCI, ANF, CME Upgraded; LPX, AZN, STV Downgraded
More News related to ANF
- Early Retail Movers: PLCE, GPS, JWN, TJX Up; ARO, AEO, KSS, URBN, ANF, JCP, COST Down
- Abercrombie & Fitch (ANF) Reports 15% Drop in October Comps
- Abercrombie & Fitch Reports October Sales Results
- Trading Review for Joe's Jeans Inc. Issued by StockPreacher.com
- Notable Analyst Rating Changes 10/19: AXP, NOV, EL, DKS Upgrade; FNM/FRE, ANF, MAT, LUV Downgrade
More News related to AZN
- Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018
- Quintiles and AstraZeneca (AZN) Enter into Pharmacology Alliance
- Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability 50 Index
- AstraZeneca's (AZN) MedImmune to Present 4 Abstracts on RSV and Influenza at 47th Annual IDSA Meeting
- MedImmune to Present Four Abstracts on RSV and Influenza at 47th Annual IDSA Meeting
More News related to CME
- CME Group Announces Substantial Completion of NYMEX Integration
- CME Group Managing Director of Products and Services to Present at Keefe, Bruyette & Woods Sixth Annual Securities Brokerage & Market Structure Conference, November 5
- CME Group Volume Averaged 10.8 Million Contracts per Day in October 2009, Up 2 Percent from September 2009
- CME Group Announces the Launch of ASCI OTC Futures
- CME Group (CME) Tops Q3 EPS by 6c
UPGRADES:
Goldman Sachs upgrades Principal Financial Group Inc. (NYSE: PFG) from Sell to Neutral and raises its price target from $18 to $20.
Wachovia Securities upgrades Johnson Controls (NYSE: JCI) to Outperform. Valuation range raised to $29-31. Click here for full color on the upgrade.
Susquehanna upgrades Abercrombie & Fitch (NYSE: ANF) from Neutral to Positive with a $33 price target, saying cost cuts and international provide upside. Click here for the full report.
JP Morgan upgrades CME Group (NYSE: CME) from Underweight to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Credit Suisse downgrades Louisiana-Pacific (NYSE: LPX) from Neutral to Underperform.
Jefferies & Co downgrades AstraZeneca (NYSE: AZN) from Hold to Underperform.
Credit Suisse downgrades China Digital (NYSE: STV) from Outperform to Neutral.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Morgan Joseph Starts L-3 Communications Holdings (NYSE: LLL) at Hold. Click here for full color on the coverage.
Soleil Securities initiates coverage on Valeant Pharmaceuticals Int (NYSE: VRX) with a Sell rating and $14 price target, saying declining base and pipeline concerns leave VRX overvalued. Here is the full report.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.11
+0.05Related Entities
- Credit Suisse
- JPMorgan
- Goldman Sachs
- Jefferies & Co
- Wachovia
- Soleil Securities
- Morgan Joseph
- Susquehanna International Group of Companies
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
